The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Biologic Therapeutics Market Research Report 2025
Synopsis
Biologic therapeutics drugs are genetically engineered proteins derived from human genetic material. They contain sugars, proteins, nucleic acids, or complex combinations of these substances, or may be living entities such as cells and tissues. In addition, biologics drugs are derived from natural sources such as animals, humans, and microorganisms that are further utilized to make therapeutic products such as vaccines, blood components, and recombinant therapeutic proteins.
The global Biologic Therapeutics market was valued at US$ 442350 million in 2023 and is anticipated to reach US$ 851340 million by 2030, witnessing a CAGR of 9.6% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Biologic Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biologic Therapeutics.
Report Scope
The Biologic Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biologic Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biologic Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Novartis Global
AstraZeneca
Merck
GlaxoSmithKline
Aurobindo Pharma
Segment by Type
Vaccines
Blood Products
Allergenic Extracts
Human Cells and Tissues
Gene Therapies
Protein
Cellular Therapies
Xenotransplantation Products
Segment by Application
Rheumatoid Arthritis
Anemia
Cancer
Diabetes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biologic Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Biologic therapeutics drugs are genetically engineered proteins derived from human genetic material. They contain sugars, proteins, nucleic acids, or complex combinations of these substances, or may be living entities such as cells and tissues. In addition, biologics drugs are derived from natural sources such as animals, humans, and microorganisms that are further utilized to make therapeutic products such as vaccines, blood components, and recombinant therapeutic proteins.
The global Biologic Therapeutics market was valued at US$ 442350 million in 2023 and is anticipated to reach US$ 851340 million by 2030, witnessing a CAGR of 9.6% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Biologic Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biologic Therapeutics.
Report Scope
The Biologic Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biologic Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biologic Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Novartis Global
AstraZeneca
Merck
GlaxoSmithKline
Aurobindo Pharma
Segment by Type
Vaccines
Blood Products
Allergenic Extracts
Human Cells and Tissues
Gene Therapies
Protein
Cellular Therapies
Xenotransplantation Products
Segment by Application
Rheumatoid Arthritis
Anemia
Cancer
Diabetes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biologic Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biologic Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Vaccines
1.2.3 Blood Products
1.2.4 Allergenic Extracts
1.2.5 Human Cells and Tissues
1.2.6 Gene Therapies
1.2.7 Protein
1.2.8 Cellular Therapies
1.2.9 Xenotransplantation Products
1.3 Market by Application
1.3.1 Global Biologic Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Rheumatoid Arthritis
1.3.3 Anemia
1.3.4 Cancer
1.3.5 Diabetes
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biologic Therapeutics Market Perspective (2019-2030)
2.2 Biologic Therapeutics Growth Trends by Region
2.2.1 Global Biologic Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Biologic Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Biologic Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Biologic Therapeutics Market Dynamics
2.3.1 Biologic Therapeutics Industry Trends
2.3.2 Biologic Therapeutics Market Drivers
2.3.3 Biologic Therapeutics Market Challenges
2.3.4 Biologic Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biologic Therapeutics Players by Revenue
3.1.1 Global Top Biologic Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Biologic Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Biologic Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biologic Therapeutics Revenue
3.4 Global Biologic Therapeutics Market Concentration Ratio
3.4.1 Global Biologic Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biologic Therapeutics Revenue in 2023
3.5 Biologic Therapeutics Key Players Head office and Area Served
3.6 Key Players Biologic Therapeutics Product Solution and Service
3.7 Date of Enter into Biologic Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biologic Therapeutics Breakdown Data by Type
4.1 Global Biologic Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Biologic Therapeutics Forecasted Market Size by Type (2025-2030)
5 Biologic Therapeutics Breakdown Data by Application
5.1 Global Biologic Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Biologic Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Biologic Therapeutics Market Size (2019-2030)
6.2 North America Biologic Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Biologic Therapeutics Market Size by Country (2019-2024)
6.4 North America Biologic Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biologic Therapeutics Market Size (2019-2030)
7.2 Europe Biologic Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Biologic Therapeutics Market Size by Country (2019-2024)
7.4 Europe Biologic Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biologic Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Biologic Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Biologic Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Biologic Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biologic Therapeutics Market Size (2019-2030)
9.2 Latin America Biologic Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Biologic Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Biologic Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biologic Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Biologic Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Biologic Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Biologic Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Biologic Therapeutics Introduction
11.1.4 Pfizer Revenue in Biologic Therapeutics Business (2019-2024)
11.1.5 Pfizer Recent Development
11.2 Novartis Global
11.2.1 Novartis Global Company Detail
11.2.2 Novartis Global Business Overview
11.2.3 Novartis Global Biologic Therapeutics Introduction
11.2.4 Novartis Global Revenue in Biologic Therapeutics Business (2019-2024)
11.2.5 Novartis Global Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Detail
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca Biologic Therapeutics Introduction
11.3.4 AstraZeneca Revenue in Biologic Therapeutics Business (2019-2024)
11.3.5 AstraZeneca Recent Development
11.4 Merck
11.4.1 Merck Company Detail
11.4.2 Merck Business Overview
11.4.3 Merck Biologic Therapeutics Introduction
11.4.4 Merck Revenue in Biologic Therapeutics Business (2019-2024)
11.4.5 Merck Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Detail
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Biologic Therapeutics Introduction
11.5.4 GlaxoSmithKline Revenue in Biologic Therapeutics Business (2019-2024)
11.5.5 GlaxoSmithKline Recent Development
11.6 Aurobindo Pharma
11.6.1 Aurobindo Pharma Company Detail
11.6.2 Aurobindo Pharma Business Overview
11.6.3 Aurobindo Pharma Biologic Therapeutics Introduction
11.6.4 Aurobindo Pharma Revenue in Biologic Therapeutics Business (2019-2024)
11.6.5 Aurobindo Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
